The past two weeks were brought to you by the letters IPO. From Facebook’s well-documented filing to this week’s IPO price cuts, a flurry of activity around SEC filings has caught the attention of VCs. Facebook filed a $5 billion IPO last week, which...

Last year was a strong year for venture capital, according to the MoneyTree report issued by the National Venture Capital Association. Investments grew 22 percent in 2011, making it the third highest year in annual investment totals over the past ten...

We’ve talked about Enterprise 3.0 before—how the evolution of social media, big data, mobile technology, Internet of Things, and cloud computing are transforming the enterprise. But more and more of the conversations at the healthcare and life sciences...

This week, Safeguard Scientifics’ life sciences team is in San Francisco attending J.P. Morgan’s 30th Annual Healthcare Conference, one of the healthcare industry’s largest annual meetings. The team is also spending time at partneringONE’s...

In the rush of the holidays, you may have missed some recent news from Safeguard Scientifics’ life sciences partner company Alverix. On December 20, 2011, Alverix announced that its partner Becton, Dickinson and Company (BD) has received 510(k)...

Recent news and predictions for venture capital have been anything but cheery. With a wobbly economy and uncertainty surrounding government reforms, investors are understandably cautious. Entrepreneur Magazine even goes so far as to ask whether venture...